Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
Clinical trial NCT02269280 · COMPLETED
Trial details
- NCT number
- NCT02269280
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2024-07-25
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.